These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6843228)

  • 1. [Role of nuclear magnetic resonance among the methods for studying xenobiotic metabolism].
    Sarrasin R; Menager S; Colboc P; Lafont M; Lafont O
    LARC Med; 1983 Jan; 3(1):22-3. PubMed ID: 6843228
    [No Abstract]   [Full Text] [Related]  

  • 2. The place of nuclear magnetic resonance spectroscopy in drug metabolism studies.
    Case DE
    Xenobiotica; 1973 Jul; 3(7):451-71. PubMed ID: 4750622
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of nonenzymatic reactions of glutathione in xenobiotic metabolism.
    Ketterer B
    Drug Metab Rev; 1982; 13(1):161-87. PubMed ID: 7044732
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonenzymatic contributions to xenobiotic metabolism.
    Testa B
    Drug Metab Rev; 1982; 13(1):25-50. PubMed ID: 7044733
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative determination of some pharmaceuticals in bulk drugs and tablets by proton magnetic resonance (PMR) spectroscopy.
    Shoukrallah I; Sakla A; Paletta B
    Farmaco; 1990 Apr; 45(4):455-63. PubMed ID: 2400518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl glucuronides: biological activity, chemical reactivity, and chemical synthesis.
    Stachulski AV; Harding JR; Lindon JC; Maggs JL; Park BK; Wilson ID
    J Med Chem; 2006 Nov; 49(24):6931-45. PubMed ID: 17125245
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of preparative high performance liquid chromatography and cryoprobe-nuclear magnetic resonance spectroscopy for the early quantitative estimation of drug metabolites in human plasma.
    Dear GJ; Roberts AD; Beaumont C; North SE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):182-90. PubMed ID: 19010088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemistry of 1,2,5-oxadiazole. 3. Synthesis and properties of 3-methyl-4-(dialkylaminoacetyl)aminofurazan and of 3-phenyl-4-(dialkylaminoacetyl)aminofurazan].
    Gasco A; Ruà G; Menziani E; Mortarini V
    Farmaco Sci; 1971 Mar; 26(3):233-46. PubMed ID: 5550051
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of preparative high performance liquid chromatography with tandem mass spectrometric directed fraction collection for the isolation and characterisation of drug metabolites in urine by nuclear magnetic resonance spectroscopy and liquid chromatography/sequential mass spectrometry.
    Plumb RS; Ayrton J; Dear GJ; Sweatman BC; Ismail IM
    Rapid Commun Mass Spectrom; 1999; 13(10):845-54. PubMed ID: 10353222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.
    Espina R; Yu L; Wang J; Tong Z; Vashishtha S; Talaat R; Scatina J; Mutlib A
    Chem Res Toxicol; 2009 Feb; 22(2):299-310. PubMed ID: 18980340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver microsomal metabolism of N-methylcarbazole: structural identification of the four major metabolites of N-methylcarbazole using 1H Fourier transform NMR spectroscopy.
    Novak RF; Koop DR; Hollenberg PF
    Mol Pharmacol; 1980 Jan; 17(1):128-36. PubMed ID: 7383015
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.
    Lindon JC; Holmes E; Bollard ME; Stanley EG; Nicholson JK
    Biomarkers; 2004; 9(1):1-31. PubMed ID: 15204308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandem mass spectrometry linked fraction collection for the isolation of drug metabolites from biological matrices.
    Dear GJ; Plumb RS; Sweatman BC; Ismail IM; Ayrton J
    Rapid Commun Mass Spectrom; 1999; 13(10):886-94. PubMed ID: 10353224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of vincarodine.
    Neuss N; Boaz HE; Occolowitz JL; Wenkert E; Schell FM; Potier P; Kan C; Plat MM; Plat M
    Helv Chim Acta; 1973 Jul; 56(7):2660-6. PubMed ID: 4761281
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics.
    Oliveira EJ; Watson DG
    Biomed Chromatogr; 2000 Oct; 14(6):351-72. PubMed ID: 11002274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia.
    Lichtenwalner DM; Suh B; Lichtenwalner MR
    J Clin Invest; 1983 May; 71(5):1289-96. PubMed ID: 6853715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite identification in drug discovery.
    Watt AP; Mortishire-Smith RJ; Gerhard U; Thomas SR
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):57-65. PubMed ID: 12613277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Online hyphenated liquid chromatography-nuclear magnetic resonance spectroscopy-mass spectrometry for drug metabolite and nature product analysis.
    Yang Z
    J Pharm Biomed Anal; 2006 Feb; 40(3):516-27. PubMed ID: 16280226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nuclear magnetic resonance study of compound 48/80.
    Ortner MJ; Sik RH; Chignell CF; Sokoloski EA
    Mol Pharmacol; 1979 Jan; 15(1):179-88. PubMed ID: 423888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.